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ZEB proteins are expressed by various
immune cells, where they can mediate
the differentiation, maintenance, and
function of these cells.
ZEB2 can regulate terminal differentiation
in murine lymphocytes via a regulatory
program that includes T-bet and ID2.
ZEB2 is required by murine plasmacy-
toid DCs (pDCs), tissue-resident
macrophages, and monocytes for theirZEB1 and ZEB2 are zinc-ﬁnger E homeobox-binding transcription factors best
known for their role in driving epithelial to mesenchymal transition. However, in
recent years our understanding of these two transcription factors has broadened,
and it is now clear that they are expressed by a variety of immune cells of both
myeloid and lymphoid lineages, including dendritic cells, macrophages, mono-
cytes, B, T, and NK cells. In these cells, ZEBs function to regulate important
transcriptional networks necessary for cell differentiation, maintenance, and
function. Here, we review the current understanding of ZEB regulation across
immune cell lineages, particularly in mice, highlighting present gaps in our knowl-
edge. We also speculate on important questions for the future.development and/or survival; in pDCs,
ZEB2 represses ID2 activity.
The precise role for ZEB2 in conven-
tional dendritic cells type 2 (cDC2s)
remains unclear because deletion of
ZEB2 has only a minor effect on murine
cDC2 numbers.
ZEB1 can regulate cytokine expression
from cDC1s upon activation with CpG.
ZEB1 and ZEB2 can play reciprocal
roles in CD8+ T cells.
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The zinc-ﬁnger E homeobox-binding (ZEB) protein family of transcription factors (TFs, see
Glossary) consists of two members; ZEB1 and ZEB2. ZEBs primarily function in mammals as
transcriptional repressors via cooperation with activated SMAD proteins and by recruitment of
either the corepressor C-terminal binding protein (CtBP) or histone deacetylase complexes,
such as nucleosome remodeling and deacetylase (NuRD) [1] (Figure 1). They are best known to
drive epithelial to mesenchymal transition (EMT) through repression of epithelial genes [2].
Although partial or complete EMT is a reversible but crucial embryonic process, aberrant
activation of EMT is also a trigger for tumor metastasis [3]. In addition to their role in EMT, ZEBs
are thought to be involved in other important cellular processes such as maintaining stemness,
promoting survival and longevity, and inducing cell-cycle arrest [4]. In recent years investiga-
tions of the role of ZEBs in the hematopoietic compartment have been initiated, and it is now
clear that ZEB2 is crucial for mammalian embryonic development [5]. Moreover, loss of ZEB2
speciﬁcally in the murine adult hematopoietic system results (after 10–12 months) in spleno-
megaly with the enlarged spleens containing a signiﬁcant inﬁltration of hematopoietic stem cells
and megakaryocyte/erythroid progenitor cells, indicative of extramedullary hematopoiesis [6,7].
In addition, within the murine immune system, ZEBs have been implicated in the development,
differentiation, and maintenance of various cell types. We review here these latest develop-
ments and our current understanding of the roles played by ZEBs across immune cell lineages.
Because Zeb2 deﬁciency is lethal, we focus on murine studies using conditional knockouts
(KOs), unless stated otherwise.University of Glasgow, Glasgow, UK
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Zeb1 and Zeb2 are widely expressed by murine myeloid immune cells. Zeb2 is expressed by
dendritic cells (DCs), macrophages, monocytes, and eosinophils, while Zeb1 is primarily
expressed by DCs and neutrophils (Figure 2). In this section, we discuss what is currently
known regarding these TFs and their role in modulating the development, maintenance, and
function of myeloid immune cells.Trends in Immunology, May 2019, Vol. 40, No. 5 https://doi.org/10.1016/j.it.2019.03.001 431
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Glossary
B-1 cells: an atypical class of self-
renewing B cells with limited receptor
repertoire that are found in peritoneal
and pleural cavities.
Bone marrow-derived dendritic
cells (BMDCs): DCs generated from
culturing bone marrow (BM)
progenitors in vitro with growth
factors such as Flt3L.
Central memory T cells (TCM):
long-lived memory
CD62L+CCR7+CD8+ T cells that
trafﬁc to lymph nodes and exhibit
high proliferation capacity upon
reactivation.
Conventional dendritic cells
(cDCs): professional antigen-
presenting cells that drive T cell
responses to antigens acquired in
the periphery.
CSF1R: colony-stimulating factor 1
receptor; binds macrophage growth
factors (CSF1, IL-33) which can
induce macrophage proliferation.
Epithelial to mesenchymal
transition (EMT): the process by
which epithelial cells become
multipotent mesenchymal stem cells.
EMT is important in development,
wound healing, ﬁbrosis, and cancer
metastasis.
E-box: a DNA consensus motif,
CANNTG, that is targeted by E-
proteins.
Effector memory T cells (TEM):
memory CD62LCCR7CD8+ T cells
that circulate through the blood and
non-lymphoid tissue, and can elicit
direct effector function.
Immgen Consortium: a consortium
of immunologists investigating the
transcriptional proﬁles of distinct
immune cells (www.immgen.org).
Innate lymphoid cells (ILCs):
innate lymphocytes derived from
common lymphoid progenitor (CLP)
cells that lack B or T cell receptors.
ILCs are further divided into subsets
based on cytokine production and
TF expression.
Kupffer cells (KCs): liver-resident
macrophages.
MicroRNAs: small noncoding RNAs
that bind speciﬁcally to target
mRNAs, thereby silencing
expression.
Memory precursor cells (MP
cells): an effector
KLRG1lowIL7RhighCD8+ T cell subset
exhibiting longevity, self-renewal, and
multipotency.
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Figure 1. The ZEB Family of Transcription Factors. Schematic representation of the two ZEB family members in
humans, ZEB1 and ZEB2. ZEB1 consists of 1117 amino acids (AA) whereas ZEB2 has 1214. These proteins are highly
homologous, and both are characterized by clusters of zinc ﬁngers at both the N- and C termini. In addition, both proteins
share a homeo (DNA-binding) domain as well as a SMAD-binding domain and a C-terminal binding protein (CtBP)
interaction domain; % indicates the extent of amino acid homology [66].ZEB2 in Dendritic Cells
DCs form the crucial link between innate and adaptive immunity, and can be divided into two
main groups, plasmacytoid dendritic cells (pDCs) and conventional dendritic cells
(cDCs). pDCs are major producers of type I interferons (IFNs) and function in modulating
immune responses to viruses [8]. Conversely, cDCs are professional antigen-presenting cells,
sampling antigen in the periphery and subsequently migrating to draining lymph nodes where
they present antigen to naïve T cells, inducing appropriate T cell responses. cDCs are further
subdivided into two subtypes; cDC1s and cDC2s [9]. cDC1s are the main cDC subset involved
in crosspresentation of antigens on MHC class I to naïve CD8+ T cells, but can also drive type 1
T helper cell (Th1) differentiation of naïve CD4+ T cells [10]. cDC2s are primarily associated
with the induction of type 2 T helper cell (Th2) and type 17 T helper cell (Th17) responses
[10]. In 2012, the ImmGen Consortium ﬁrst reported that Zeb2 was expressed by murine
pDCs and cDC2s, but was absent from cDC1s [11]. These ﬁndings were then extended to
show that Zeb2 expression was downregulated during cDC1 development, with its expression
decreasing as cells transitioned from common DC progenitors (CDPs) to cDC1-committed
precursors (pre-cDC1s), and ﬁnally to mature cDC1s [12]. Conversely, Zeb2 expression was
consistently maintained throughout cDC2 development and maturation [13].
Stimulated by these ﬁndings, we and others, used various conditional genetic approaches,
including the Itgax–Cre (CD11c–Cre) and Mx1–Cre models crossed to Zeb2ﬂ/ﬂ mice, to
examine the requirement for ZEB2 expression by DCs [7,14]. pDCs were found to require
ZEB2 in a dose-dependent manner for their development and/or maintenance in tissues
(Figure 3), and loss of one or both copies of Zeb2 resulted in a reduction or loss of splenic
pDCs, respectively, compared with wild-type (WT) controls [7,14]. In addition, retrovirus-driven
overexpression of Zeb2 in Kithi bone marrow (BM) progenitors increased pDC numbers
following in vitro treatment with FMS-like tyrosine kinase 3 ligand (Flt3L), relative to control
cultures [7] (Figure 3). In terms of mechanism, Zeb2 deletion in both models resulted in
increased expression of inhibitor of DNA binding 2 (Id2) compared with control pDCs [14].
ID2 is known to block pDC development by antagonizing the E-protein E2-2 [transcription
factor 4, (TCF-4)] [15–17], suggesting that ZEB2 may regulate pDC development by repressing
ID2. Direct repression of ID2 by ZEB2 was conﬁrmed using chromatin immunoprecipitation
(ChIP) [14].432 Trends in Immunology, May 2019, Vol. 40, No. 5
Mowat–Wilson syndrome: a rare
human genetic disorder caused by
de novo loss-of-function mutations or
monoallelic deletion of ZEB2. Major
symptoms include distinctive facial
features, intellectual disability,
delayed development, and in some
cases an intestinal disorder termed
Hirschsprung disease.
MutuDC: a cDC1-like cell-line
derived from splenic tumors from
CD11c:SV40LgT transgenic C57BL/6
mice.
Mx1–Cre: an inducible Cre line
activated by interferons or double-
stranded RNA such as poly(I:C).
Necroptosis: a programmed form of
inﬂammatory cell death.
Plasmacytoid dendritic cells
(pDCs): a DC subset that produces
large quantities of IFN in response to
viruses.
Pre-pro-B cell: the earliest B cell
progenitor; expresses B220 and has
germline Ig genes.
Pro-B cell: the second step in B cell
development. These cells express
CD19 and rearrange their IgM genes.
Stemness: a cellular gene
expression proﬁle that underlies the
potential for self-renewal and
multipotency.
Tgd cells: a subset of
‘unconventional’ T cells activated in
an MHC-independent manner; they
express heterodimeric TCRs
composed of g and d chains.
Terminal effector cells (TE):
effector KLRG1highIL7RlowCD8+ T
cells with reduced longevity and
proliferative capacity, as well as
restricted plasticity.
Tissue-resident memory T cells
(TRM): memory CD8
+ T cells residing
in non-lymphoid tissues; they provide
a ﬁrst-line of defense upon pathogen
reinfection.
Transcription factors (TFs): bind
to speciﬁc DNA sequences mediating
gene transcription.
T regulatory cells (Tregs):
FOXP3+CD4+ T cells that suppress
inﬂammation and maintain tolerance.
Type 1T helper cells (Th1): T-
BET+IFN-g+CD4+ T helper cells that
defend the body against intracellular
pathogens.
Type 2T helper cells (Th2):
GATA3+IL-4+IL-13+CD4+ T helper
cells that defend the body against
extracellular pathogens.
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Figure 2. ZEB Expression in the Murine Immune System. For illustrative purposes in this review, a heatmap is
shown detailing relative transcript expression levels of Zeb1 and Zeb2 across mouse immune cells. Data are a compilation
of that generated by the ImmGen Consortium (www.immgen.org) or in-house [14,25,35]. Microarray and bulk RNA-Seq
data were processed separately. Microarray: data were analyzed using the limma R package (Bioconductor). The robust
multi-array average (rma) procedure was used to normalize data within arrays (probeset summarization, background
correction, and log2 transformation) and between arrays (quantile normalization). Only probesets that mapped uniquely to
one gene were retained, and for each gene the probeset with the highest expression level was retained. Bulk RNA-Seq:
normalization was performed using the calcNormFactors function of the edgeR package (Bioconductor) with default
parameters. Normalized counts were subsequently transformed to log2 values using the voom function of the limma R
package. Values shown were obtained by calculating the mean expression per gene and subtracting this from each log2-
normalized value of that gene. Separate heatmaps were created for microarray and bulk RNA-Seq data. Both heatmaps
use the same color legend.In cDCs, the exact role played by ZEB2 appears to be slightly more complex. As observed for
pDCs, conditional KOs of Zeb2 led to reduced numbers of splenic cDC2s relative to WT;
however, this reduction was minor compared with the almost complete ablation of pDCs in the
absence of Zeb2 [7,14]. Nevertheless, although Zeb2 loss only resulted in a minor reduction in
cDC2 numbers, ZEB2 was found to be intrinsically required for the development of cDC2s, with
fewer cDC2s originating from Zeb2/ versus Zeb2+/+ BM in a competitive BM chimera setting
[7,14]. One possible explanation for this is that ZEB2 may not regulate the entire cDC2 lineage,
but instead regulates an undeﬁned subset (Figure 3 and Box 1), although this remains to be
tested. Fitting with this idea, the impact of Zeb2 deﬁciency (in terms of cDC2 numbers) varied
between tissues in this study. For example, in the liver, Zeb2 deletion resulted in ﬁvefold fewer
cDC2s relative to WT controls, but only a 1.5-fold and 2.5-fold reduction in the spleen and lung,
respectively [14]. Moreover, when cDC2s in the small-intestine lamina propria were further
subdivided based on CD103 expression, only the CD103 cDC2s were found to partially
depend on ZEB2, being reduced in numbers in Zeb2-deﬁcient mice compared with WTTrends in Immunology, May 2019, Vol. 40, No. 5 433
Type 17 T helper cells (Th17):
RORgT+IL-17+CD4+ T helper cells
that play a role in the induction of
tissue inﬂammation/destruction.
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(Figure legend continued on the bottom of the next page.)
Role of ZEBs in Murine Myeloid Immune Cells. Myeloid immune cells develop primarily in the bone marrow
from HSCs, and subsequently migrate into the blood and tissues where they exert their functions or further differentiate into
mature cells which then carry out their speciﬁc roles. The main exceptions to this are tissue-resident macrophages that
primarily develop from either yolk-sac macrophages or fetal liver monocytes during embryogenesis, with a contribution
from BM monocytes in adulthood in some tissues such as the gut and skin. The role of ZEBs in this differentiation process
and in the maintenance/function of mature myeloid cells has recently begun to be elucidated, and demonstrated roles (red
font) for ZEB2 have been identiﬁed in monocytes, pDCs, cDCs, and macrophages. On the one hand, ZEB2 must be absent
for cDC1 development, and is downregulated from CDP to pre-cDC1 to cDC1 stages. On the other, ZEB2 is required by
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Box 1. ZEB2 and DCs: A Cellular Fate Switch?
Despite largely overlapping data, different conclusions regarding the role of ZEB2 in murine DCs have been reached.
Our laboratory proposed that, in addition to being important for pDCs, ZEB2 can act as a fate switch between cDC1s
and cDC2s [14]. However, the laboratory of Ken Murphy concluded that ZEB2 does not play a role in cDC2 biology but
instead that it can act as a fate switch between pDCs and cDC1s [7]. In line with previous reports suggesting that pDC
development is regulated by TFs at the expense of cDC1s [17,63]. Our hypothesis was based on observations that
cDC1s or cDC2s acquired features of one another upon overexpression or loss of Zeb2, respectively and because the
minor effects of Zeb2 deﬁciency in cDC2s were cell-intrinsic [14]. The latter hypothesis was based on the idea that pDCs
and cDC1s arise from a common dendritic cell progenitor (CDP), however, the validity of this model is now being
questioned [64]. Thus, it is clear that we do not yet fully understand how ZEB2 controls the DC lineage, and further
investigation is necessary. In line with this, one key question concerns why there is only a minor reduction in cDC2s upon
loss of ZEB2. One possibility is that ZEB2 is only required by a subset of cDC2s. In T cells, ZEB2 has been suggested to
function primarily in the later stages of differentiation; thus it might be tempting to speculate a similar occurrence within
cDC2s. However, our results suggest that ZEB2 is required early in cDC2 development, rather than late, given that loss
of ZEB2 later in cDC2 development appears to have no effect on cDC2 numbers (when ZEB2 loss is driven by the ‘late-
Itgax–Cre’, where CRE expression is only detected after the pre-cDC stage) [14]. By contrast, it is possible that distinct
subsets of cDC2s might already be present at the pre-cDC stage. If this is the case, what are these subsets and which
factors induce them? In terms of the role of ZEB2 in cDC1s, key questions include when and how is Zeb2 down-
regulated during progression from the CDP to cDC1s?controls. Intestinal CD103+ cDC2s were unaffected (in terms of number) by the absence of
Zeb2 [14]. Concomitantly, intestinal CD103 cDC2s also displayed higher Zeb2 expression
than their CD103+ counterparts [14]. Similarly to the effects observed for pDCs, increased Id2
expression was also reported in Zeb2/ cDC2s and their immediate precursors relative to WT
controls [7,14]; this suggested that ZEB2 might also function in cDC2s to repress ID2, which is
required for cDC1 but not cDC2 development [16,18]. Further studies should clarify this
possibility.
Reciprocally, in terms of cDC1s, deletion of Zeb2 resulted in a slight increase relative to WT in
the proportion and number of these cells in a cell-intrinsic manner [7,14] (Figure 3). Moreover,
overexpression of Zeb2 in CD11c-expressing cells using the Rosa-26 promoter but not the
retroviral transduction system resulted in a decrease in cDC1s relative to WT controls [7,14].
The cause of the different results between laboratories is unclear, but it is notable that, in the
retroviral transduction system, cDCs in general were largely lacking compared with controls [7].
In addition to reduced cDC1s, Zeb2 overexpression in CD11c+ cells resulted in a novel
population of splenic cDCs with a mixed cDC1 and cDC2 phenotype expressing XCR1
and SIRPa [14], suggesting that expression of Zeb2 in cDC1s might induce a switch to a
more cDC2-like phenotype, a ﬁnding corroborated by RNA-Seq [14]. Although the data
presented are consistent between the two laboratories, our group suggested that ZEB2 might
act as a fate switch between cDC1s and cDC2s [14]; however, a role for ZEB2 as a fate switch
between pDCs and cDC1s has also been suggested [7], and further work will therefore be
necessary to fully understand the role played by ZEB2 in cDC biology (Box 1 and Outstanding
Questions). A ﬁnal key question left unanswered concerns whether ZEB2 regulates DC function
during an immune response. Although the studies described above demonstrate a role for
ZEB2 in DC development, these studies did not assess DC function in the absence of Zeb2.cDC2s, but its deletion causes only a partial reduction in cDC2s. This could be because cDC2s have a minimal requirement
for ZEB2 or because there are multiple subsets of cDC2s that derive from distinct pre-cDC2s, and only one of these
subsets is ZEB2-dependent. Further work will be necessary to understand this. ZEB1 has been implicated (red font) in the
function of cDC1s, although its role in maintaining this population is unclear. A role for either ZEB1 or ZEB2 remains to be
investigated (blue font) for some precursors as well as for neutrophils, eosinophils, and monocyte-derived macrophages
recruited during inﬂammation/infection. Abbreviations: cDC, conventional dendritic cell; CDP, common dendritic cell
progenitor; CLP, common lymphoid progenitor; CMP, common myeloid progenitor; GMP, granulocyte/macrophage
progenitor; HSC, hematopoietic stem cell; MDP, macrophage/dendritic cell progenitor; pDC, plasmacytoid dendritic cell.
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The models used were not sufﬁciently speciﬁc to limit Zeb2 deletion to a particular DC subset or
even to DCs in general; it is therefore very difﬁcult to ascribe a DC or DC subset-speciﬁc function
to ZEB2. In the future, ex vivo studies using ﬂuorescence-activated cell sorting (FACS)-puriﬁed
cells or in vivo studies using novel, speciﬁc CRE lines may help to understand any conse-
quences of Zeb2 loss on DC function.
ZEB1 in Dendritic Cells
Although considerable progress has been made in understanding the role of ZEB2 in DCs, our
knowledgeregardingtheroleofZEB1isstill limited.UnlikeZeb2,Zeb1 isexpressedacrossmostDC
subsets in mice (Figure 2). Recently, one study examined the role of ZEB1 in the murine tumor-
derived DC cell line (MutuDC) [19] previously reported to resemble splenic cDC1s [20]. This study
found that knocking down Zeb1 in MutuDCs led to their impaired activation upon stimulation with
the toll-like receptor 9 (TLR9)agonist CpG, andCpG-activationofZeb1-deﬁcientMutuDCs skewed
T cell differentiation towards a Th2 rather than a Th1 response; relative to controls, this was
evidenced by a slight increase in GATA3+interleukin (IL)-13+ Th2 cells and reduced T-bet+IFN-g+
Th1 cells following DC:T cell coculture [19] (Figure 3). Transient Zeb1-deletion in mouse Flt3L-
derived CD11c+CD24+bone marrow-deriveddendriticcells (BMDCs) also resulted in impaired
cytokine secretion upon stimulation with CpG compared with WT controls [19]. Although these
resultssuggest thatZEB1 mayplay a role inmodulatingDCactivationandthesubsequent induction
of T cell responses, in this study the effect of deleting Zeb1 on the development of cDC1s was not
addressed and remains to be determined. In addition, with the caveats associated with the use of in
vitro DCs – that do not fully recapitulate bona ﬁde tissue cDC1s – it will be intriguing to see if these
results can be reproduced either in vivo, or by using alternative in vitro ‘cDC1’ culture systems [21]
including those culturing human cDC1s [22].
ZEB2 in Monocytes and Neutrophils
Monocytes represent a highly heterogeneous population with many distinct functions, both under
homeostatic and inﬂammatory conditions [23]. They are commonly characterized by the expres-
sion of CD11b, CD115 (macrophage colony-stimulating factor receptor MCSFR, also known as
CSF1R), and varying expression of Ly6C (mouse) or CD14 and CD16 (human). Monocytes
develop in the BM from common myeloid progenitor (CMP) cells, which subsequently differentiate
into granulocyte/macrophage progenitor (GMP) cells, giving rise to either granulocytes or macro-
phage/dendritic cell progenitors (MDPs); MDPs in turn generate monocytes or DCs (Figure 3). In
mice, the two best-characterized subsets of monocytes are referred to as Ly6Chi and Ly6Clo
monocytes, with the latter deriving from the former [23]. Notably, both subsetsexpress and require
Zeb2 (Figures 2 and 3), as evidenced from experiments where induced deletion of Zeb2 (Mx1–Cre)
resulted in a cell-intrinsicprolonged reduction of both subsets in the BM, blood, and spleen relative
to WT mice [6,7]. Mechanistically, this was attributed to reduced expression of Csf1r upon loss of
Zeb2, perhaps through upregulation of Id2 [7]. This would be consistent with a report suggesting
that ID2 can repress PU.1-mediated induction of Csf1r [24]. Also in agreement with this hypothe-
sis, downregulation of Csf1r expression was also observed in Zeb2-deﬁcient tissue-resident
macrophages across tissues, relative to WT controls [25] (Box 2 and below). However, the
reduced expression of Csf1r in Zeb2-deﬁcient Kupffer cells (KCs) was not sufﬁcient to prevent
CSF1–Fc-mediated proliferation [25,26]; this suggested that the ability of these macrophages
(and possibly monocytes) to signal through CSF1R might not be completely abrogated upon loss
of Zeb2. Similarly to the DCs, the functional consequences of Zeb2 loss in monocytes could not be
formally examined owing to non-speciﬁcity of the CRE.
Despite expressing Zeb2 in blood and tissues, neutrophils have not been shown to be affected
by the deletion of Zeb2 (Figure 2) [7]. At ﬁrst glance, this seems to contrast with data from436 Trends in Immunology, May 2019, Vol. 40, No. 5
Box 2. Common Features and Networks of ZEB2 across Murine Immune Cells
Deletion of Zeb2 results in many cell/tissue-speciﬁc aberrations; however, some conserved features have been
identiﬁed. One of these is the downregulation of Csf1r expression in Zeb2-deﬁcient myeloid cells [7,14,25]. In addition,
many Zeb2-deﬁcient macrophages exhibit upregulated expression of Siglecf, Cd101, Epcam, and Ms4a1, or some
combination thereof [25]. Expression of Siglecf and Ms4a1 is also upregulated in Zeb2-deﬁcient monocytes [7], whereas
Siglecf, Epcam, and Cd101 are upregulated in Zeb2-deﬁcient cDC2s [14]. Moreover, small-intestinal CD103+ cDC2s
(ZEB2-independent) also express Siglecf, Epcam, and Cd101 compared with their CD103 (partially ZEB2-dependent)
counterparts [14,65]. Taken together, this suggests a putative common ZEB2 gene signature in myeloid cells. Of note,
altered expression of these surface receptors might be potentially considered as a good surrogate for identifying Zeb2-
deﬁcient myeloid cells because antibody staining for ZEB2 is often unreliable [25].
Studies into the role of ZEB2 in lymphoid cells have indicated that ZEB2 exists within a larger conserved regulatory
network in partnership with T-bet [48,49,59]. T-bet is required for the expression of Zeb2, and gene expression proﬁling
or extensive ﬂow cytometry in effector T cells and NK cells has shown that ZEB2 and T-bet can regulate the expression
of a common set of genes or proteins in these cells [48,49]. T-bet ChIP-Seq analyses in CD8+ T cells have indicated that
T-bet exhibits enriched binding at genes coregulated by ZEB2, and furthermore that Zeb2 deﬁciency can alter such T-
bet binding [49]. Moreover, retroviral overexpression of T-bet in ZEB2-deﬁcient T cells responding to LCMV-Arm
infection only partially rescued the KO phenotype, suggesting that ZEB2 and T-bet might be non-redundant, and might
cooperate to repress MP genes, but also upregulate TE genes [49]. Taken together, T-bet appears to regulate gene
expression early, inducing Zeb2 expression, and this presumably helps to reinforce T-bet actions; this suggests that a
feed-forward loop might exist to induce terminal differentiation [49,59].
Altered Id2 expression has been deemed to be a common feature of Zeb2-deﬁcient immune cells [7,14,25,48,49,59]. In
myeloid cells, ZEB2 can repress ID2, whereas in lymphoid cells ZEB2 can cooperate with ID2. ZEB2 shares a DNA-
binding motif with E-proteins, and in lymphoid cells is predicted to work in partnership with ID2 to inhibit E-protein
activity [48]. However, pDCs require the E-protein E2-2 for their development ereas and ID2 antagonizes this [15]. Id2
expression is also upregulated in Zeb2-deﬁcient cDC2s, monocytes, and tissue-resident macrophages [7,14,25],
although the signiﬁcance of this remains unclear. It will be interesting to delineate which are the cooperative versus
competing roles of ZEB2 and ID2 in different immune cells to better understand their functional roles.another study reporting an increase in Ly6G+CD11b+ granulocytes and Ly6GintCD11b+ ‘imma-
ture granulocytes' 8 weeks after inducing Zeb2 loss, relative to WT controls [6]. However, this
was only observed when the relative percentages of these cells were examined [6]. In BM
chimera settings (competitive and noncompetitive), Zeb2-deﬁcient progenitors did not show
any increased intrinsic potential to generate granulocytes [6], thus leading to the hypothesis that
ZEB2 might not be intrinsically required by neutrophils, but instead that the increase in
neutrophil subsets observed may have been due to altered proportions of other cells. Notably,
the remaining monocytes in Zeb2-deﬁcient mice were found to upregulate the expression of
several neutrophil- or GMP-related genes. These include Cebpe and Zeb1 (also present in
neutrophils) and other genes including Camp, Mmp9, and Ltf (expressed by neutrophils) as well
as Mpo, Elane, and Prtn3 (expressed by GMPs) [7]. It is thus possible that, similarly to its role in
other myeloid cells, ZEB2 may act in monocytes as a regulator of cell identity, with its deletion
skewing monocytes towards an alternative fate, such as the neutrophil lineage, or perhaps
preventing GMP maturation and differentiation (Figure 3). However, this remains speculative at
this point. Moreover, the function of ZEB1 in monocytes and neutrophils also remains to be
studied. Investigating these possibilities thus represents an interesting goal for the future (see
Outstanding Questions).
ZEB2 in Macrophages
Macrophages are present in almost every tissue in the body, and have unique tissue-speciﬁc
transcriptional and epigenetic proﬁles, or ‘tissue identities’ [25,27–31]. Although best known for
their role in immunity, particularly as scavengers of foreign material, the unique proﬁles of tissue-
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functions' for their speciﬁc tissues, such as synaptic pruning by brain microglia [32] or the
clearance of excess surfactant by lung alveolar macrophages [33–35]. Despite arising from a
limited number of possible progenitors (either yolk-sac macrophages, fetal liver monocytes, or
BM monocytes [36]), tissue imprinting of tissue-resident macrophages results in very few genes
being conserved across the macrophage lineage. Comparison of the transcriptional proﬁles of
different murine tissue-resident macrophages with other immune cells yielded a list of only 67
genes whose expression was conserved across the entire tissue-resident macrophage lineage,
and one of these genes was Zeb2 [25]. Moreover, Zeb2 expression does not appear to be
limited to mature tissue-resident macrophages but is also expressed at the pre-macrophage
stage during embryonic development [28] and, possibly, in monocyte-derived macrophages
recruited under nonhomeostatic conditions, although this remains to be further validated
(Figure 3). Deletion of Zeb2 from ﬁve different tissue-resident macrophage populations (liver,
lung, brain, spleen, and colon) driven by either Fcgr1–Cre, Clec4f–Cre, or Itgax–Cre, resulted in
unique tissue-speciﬁc changes in macrophage transcriptomes [25]. Zeb2/ macrophages
were lost from tissues over time, likely through necroptosis, and were replaced by Zeb2-
expressing macrophages, either having escaped Zeb2 deletion or having been newly recruited
to accessible niches [25,36]. Despite reduced expression of Csf1r by Zeb2-deﬁcient macro-
phages relative to controls, macrophage loss was not a result of the inability of these macro-
phages to proliferate in response to CSF1; indeed, proliferation was observed following
administration of CSF1–Fc [25,26]. Compared with WT macrophages, Zeb2 haploinsufﬁciency
did not result in macrophage death but did change the transcriptomic proﬁles of these cells [25].
Because ZEB2 haploinsufﬁciency in humans through de novo loss of function mutations or
deletion of the dominant ZEB2 allele leads to Mowat–Wilson syndrome [37], it will be
interesting to further study the precise effects of the monoallelic loss of Zeb2 speciﬁcally in
macrophages (see Outstanding Questions).
Exactly how ZEB2 maintains tissue-resident macrophage identities across different tissues
remains unclear. Further analysis of KCs revealed that loss of the core KC TF, liver X receptor a
(LXRa) [25], was a major driving force behind identity loss. Deletion of LXRa (Nr1h3) speciﬁcally
from KCs also resulted in loss of KC identity, with many of the same genes being down-
regulated compared with Zeb2 deﬁciency [25]. However, this overlap was not 100%, and
deletion of Zeb2 had a greater effect than removing LXRa alone; this suggested that ZEB2
might have additional roles in KCs instead of solely modulating LXRa expression; however, this
remains to be studied further. Similarly, the loss of Zeb2 from alveolar macrophages (AM) of the
lung led to downregulation of Cebpb (encoding CCAAT/enhancer binding protein b; CEBPb), a
TF proposed to be important for the maintenance of murine AMs [38]. However, whether this is
a general mechanism whereby ZEB2 regulates expression of tissue-speciﬁc TFs in different
macrophage populations remains to be seen. Another outstanding question is whether ZEB2
can directly regulate the expression of these tissue-speciﬁc TFs, for example LXRa in KCs. As
mentioned, ZEB2 is primarily considered to be a transcriptional repressor; however, if ZEB2 can
directly regulate LXRa expression, it might point to a role in transcriptional activation. This is an
interesting future question because it may reveal further functional roles for ZEB2 (see Out-
standing Questions).
Finally, the function of ZEB2 in macrophages during an immune response remains unclear. In
the conditional KO models described to date, a Zeb2-sufﬁcient population of macrophages
was maintained in almost all tissues studied [25]. Therefore, it remains to be established
whether there are any in vivo experimental conditions that will allow a functional assessment of
Zeb2-deﬁcient macrophages without compensation from Zeb2-expressing cells. Examining
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Zeb2 in macrophages recruited during inﬂammation, represent important goals for future
investigations (Figure 3 and see Outstanding Questions).
ZEB1 and ZEB2 in Lymphoid Cells
The generation of naïve lymphocytes and their subsequent differentiation to effector cells is
driven by complex and precisely regulated transcriptional networks. Zeb1 and Zeb2 expression
is dynamically regulated through this process (Figure 2); however, their roles in developing cells
committed to the lymphocyte lineage are only beginning to be uncovered. In this section, we
highlight the role of ZEBs in B, T, and NK cell development, focusing on recent studies
describing ZEBs as transcriptional regulators of effector lymphocyte populations.
ZEB2 in B Cells
B cells are a crucial component of the adaptive immune system that provides humoral and cellular
protection against a wide array of pathogens. Although the precise role ZEB2 plays over the
lifespan of a B cell is undeﬁned, it is clear that ZEB2 is necessary for the development of mature
populations. Speciﬁcally, induced deletion of Zeb2 in adulthood has not been shown to affect
common lymphoid progenitor (CLP)cells in the BM, but led to near-complete loss of mature B cells
in blood [6]. Closer examination revealed a block in B cell differentiation at the transition from a pre-
pro-B cell to a pro-B cell [6]. IL-7signaling isknown tobe important for this transition [39,40], and
pre-pro-B cells lacking Zeb2 exhibited severely reduced expression of Il7r relative to WT controls.
Stimulation of these cells with IL-7 yielded no detectable activation of the JAK/STAT pathway [6],
demonstrating that IL-7 signaling was impaired. Thus, dysregulation of Il7r expression is likely –
and at least in part – to be responsible for the block in B cell maturation [6].
The role of ZEB2 in the maintenance and function of mature B cell populations could not be
studied using this model. Nevertheless, increased Zeb2 expression is observed in mouse
peritoneal cavity B-1 cells compared with other subsets (www.immgen.org) (Figure 2). Thus,
future experiments examining the transcriptional requirements for mature B cells subsets at
steady-state, following infection, or in cases of autoimmunity would prove informative. Fur-
thermore, Zeb1 is also expressed across B cell populations, although less dynamically than
Zeb2 (www.immgen.org) (Figure 2). Although no studies examining its role in the B cell lineage
have been described, it will be important to understand how ZEB family members participate in
the differentiation of mature B cells (see Outstanding Questions).
ZEB1 and ZEB2 in T Cells
T cells are central arbiters of cell-mediated immunity against bacterial and viral infections as well
as against tumors. T cell development and thymic selection is a complex process involving
multiple transcriptional regulators [41]. Analysis of ImmGen datasets revealed dynamic expres-
sion of Zeb1 and Zeb2 in T cells (www.immgen.org) (Figure 2). Early studies in mice demon-
strated a crucial role for ZEB1 in mediating T cell development, likely through the repression of E
box-containing genes such as Cd4, Il2, Gata3, and Itga4 [42–45]. By contrast, in the absence
of Zeb2 expression, murine adult hematopoiesis was minimally affected and blood T cell
numbers were comparable with those of WT controls [6]. However, in a competitive BM
transplant setting, Zeb2-deﬁcient hematopoietic stem and progenitor cells (HSPCs) exhibited
an impaired ability to reconstitute most cell lineages, including circulating T cells, 16 weeks after
transplant [6]. This may suggest either that ZEB2 is dispensable for T cell development or that
compensatory mechanisms for loss of Zeb2 may exist. After development in the thymus, naïve,
effector, and memory T cells engage transcriptional networks to integrate environmental stimuli
and to shape and maintain their cellular state. As described in the next section, recent work has
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ZEB2 in Mature CD8+ T Cells
In response to infection or malignant transformation, naïve antigen-speciﬁc CD8+ T cells become
activated and differentiate to form a pool of effector T cells that provide acute protection [46].
Although the majority of effector CD8+ T cells are considered to be terminally differentiated
(terminaleffector cells, TEs) and die at the resolution of an immune response, a small proportion
of less-differentiated effector T cells act as memory precursor cells (MPs) and survive to seed
the long-lived memory population [46]. CD8+ memory T cells can broadly be divided into three
subsets: effector memory T cells (TEM), central memory T cells (TCM), and tissue-resident
memory T cells (TRM). TEM and TCM are found in circulation where the shorter-lived, more
differentiated TEM can elicit direct effector function to provide immediate protection upon reinfec-
tion (e.g., with a virus), whereas long-lived TCM exhibit more stem-like properties [46]. TRM are
permanently lodged in non-lymphoid tissues and provide sentinel immunosurveillance [46].
Unique transcriptional signatures regulating effector and memory T cell differentiation have been
described, and in both humans and mice, high Zeb2 expression has been observed in the most-
differentiated terminal effector and TEM populations relative to other subsets (Figure 2) [47].
Using conditional mouse models where Zeb2 was deleted in the developing T cell population, or
shortlyafter T cell activation,weand others investigated the functionofZEB2 ineffector CD8+T cell
differentiation during acute lymphocytic choriomeningitis virus (Armstrong strain; LCMV-Arm)
infection. At the peak of the response, Zeb2/ effector CD8+ T cells failed to accumulate in the
blood, spleen,orperipheral tissues [48,49]. However, byday60 following infection, Zeb2-deﬁcient
and WT T cell numbers in the spleen were comparable [49]. Moreover, despite normal function-
ality, Zeb2-deﬁcient effector T cells generated signiﬁcantly fewer of the most differentiated
(KLRG1hiIL7Rlo) TE cells relative to WT controls. The TE cells that did form, exhibited reduced
expression of effector-signature molecules and increased amounts of pro-memory molecules
relative toWTcontrols [48,49]. Incontrast towhathas been observed inmyeloidcells (Box2),Zeb2
expression has been found to correlate with the expression of Tbx21 and Id2–both key drivers of
the KLRG1hiTE subset [50–54]. Thus, Zeb2 likely acts in a larger transcriptional network with T-bet
and ID2, regulating genes that are necessary for the formation of the TE effector and effector-
memory CD8+ T cell state, while restricting memory cell potential [48,49].
Furthermore, in the acute LCMV infection model, Zeb2-deﬁcient memory T cells produced more
IL-2, and expressed more CD62L (L-selectin) and BCL-2, but less KLRG1, than WT controls,
suggesting that in the absence of Zeb2 the formation of less differentiated TCM was accelerated;
this appears to further supporta role forZEB2 in theprogramming ofa more differentiated cell state
[49] (Figure 4). Homeostatic turnover and cytokine production by antigen-speciﬁc memory
Zeb2/ CD8+ T cells was comparable with that of WT cells [49]. However, Zeb2/ antigen-
speciﬁc memory CD8+ T cells [endogenous or T-cell receptor (TCR) transgenic], were shown to
generate fewer secondary effector CD8+ T cells following acute virus or bacteria rechallenge [48].
In contrast, another study found that, when equal numbers of memory CD8+ T cells were
transferred to naïve mice subsequently infected with LCMV (clone 13, chronic infection model),
Zeb2-deﬁcient CD8+ T cells expanded to similar numbers and controlled viral burden to the same
extent as WT memory CD8+ T cells [49]. This discrepancy may be the result of differing experi-
mental protocols, and needs to be further analyzed. Nevertheless, based on these overall ﬁndings,
we speculate that ZEB2 might regulate memory differentiation but not memory homeostasis or
function. Further experiments are warranted to assess this possibility.
ZEB1 in Mature CD8+ T Cells
Whereas Zeb2 is upregulated upon CD8+ T cell activation, and is most highly expressed in T
cells at the effector phase following viral infection in mice (e.g., LCMV), Zeb1 expression440 Trends in Immunology, May 2019, Vol. 40, No. 5
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Figure 4. ZEB-Mediated Regulation of Murine Lymphocyte Differentiation States. Although ZEB2 is crucial for
murine B cell development in the bone marrow, it is primarily the mature lymphocytes that depend on ZEB transcription
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cell.appears to be inversely regulated [55] (Figure 4). Naïve CD8+ T cells express high Zeb1 that
decreases following T cell activation, and which is then upregulated again in memory T cells
[55]. Eight days following acute LCMV-Arm infection, murine MP T cells exhibited increased
expression of Zeb1 relative to TE T cells, in a reciprocal manner to Zeb2 [55]. Similarly, Zeb1
expression was increased in Zeb2-deﬁcient bulk effector CD8+ T cells relative to WT controls,
and Zeb2 expression was elevated in Zeb1-deleted memory CD8+ T cells, suggesting that
ZEB1 and ZEB2 might repress the expression of each other. Accordingly, ChIP-qPCR dem-
onstrated direct ZEB1 binding to the murine Zeb2 promoter in WT naïve CD8+ T cells, although
direct ZEB2 binding to ZEB1 could not be conﬁrmed because a ZEB2 antibody was unavailable
[55]. In contrast to EMT, where ZEB1 and ZEB2 can function together to drive EMT [4], here,Trends in Immunology, May 2019, Vol. 40, No. 5 441
ZEB family members appear to be expressed during distinct phases of the immune response to
modulate transcription (Box 3).
Related to this, using a mouse model of Zeb1 deletion speciﬁcally in activated T cells, Zeb1-
deﬁcient CD8+ T cells displayed an opposite phenotype to that of Zeb2-KO T cells [55].
Speciﬁcally, CD8+ T cells lacking Zeb1 underwent clonal expansion following LCMV-Arm
infection, but declined in numbers over time, in comparison with WT controls. Both survival
and homeostatic proliferation in memory CD8+ T cells were impaired in the absence of Zeb1
compared with the WT population [55]. Moreover, Zeb1-deﬁcient T cells produced less IL-2
and expressed less CD62L, CD122, or eomesodermin than WT controls  all properties of
TCM; this suggested that a more differentiated cell type appears to be favored in the absence of
Zeb1. Following this, equal numbers of WT and Zeb1-deﬁcient LCMV-speciﬁc memory CD8+ T
cells were adoptively transferred to naïve hosts and examined after secondary infection with
Listeria monocytogenes expressing the LCMV GP33–41 epitope; mice receiving Zeb1-deﬁcient
cells exhibited impaired expansion of CD8+ T cells, reduced expression of cytotoxic granzyme
B, and diminished control of bacterial burden, compared with mice receiving WT CD8+ T cells
[55]. This demonstrated that ZEB1 can play a role in the establishment, maintenance, and
execution of some functions in long-lived CD8+ T cell memory [55].
Taken together, these results appear to highlight reciprocal roles for ZEB1 and ZEB2 in the
regulation of CD8+ T cell responses. Although ZEB2 can promote TE cell differentiation and
survival, ZEB1 is required for normal maintenance of memory CD8+ T cells and protective
immunity. A key question then arises – how is this division of labor controlled? In a recent study,
microRNA 200 (miR-200) family members and the cytokine, transforming growth factor (TGF)-
b, two factors important for regulating ZEB1 and ZEB2 expression in EMT, were positioned asBox 3. Repurposed Regulation of ZEBs
In EMT, ZEB family members operate together in a well-described double-negative feedback loop [4]. Stromal factors
including TGF-b stimulate EMT by activating transcriptional regulators including ZEBs, whereas miR-200 family
members can repress these drivers to maintain epithelial identity. In mammals, both ZEB1 and ZEB2 contain miR-
200 binding sites in their 30-untranslated regions (UTRs) and, in turn, ZEB1 and ZEB2 can directly repress miR-200
expression [4].
During mature CD8+ T cell differentiation, this regulatory network appears to become uncoupled: ZEB1 and ZEB2 seem
to work on two different branches of CD8+ T cell differentiation. TGF-b signaling leads to increased Zeb1 but decreased
Zeb2 expression, whereas the expression of miR-200 members mirrors that of Zeb1 in CD8+ T cells responding to
LCMV-Arm infection; this in turn indicates that Zeb1 can escape miR-200-mediated transcriptional repression [55].
Retroviral overexpression of miR-200a or miR-200c can reduce Zeb2, but not Zeb1, expression in LCMV-speciﬁc
effector CD8+ T cells, resulting in substantially reduced numbers of TE cells at day 8 post-infection relative to controls
[55]. In this study, miR200-deﬁcient antigen-speciﬁc memory CD8+ T cells showed increased Zeb2 expression and
decreased Zeb1 expression relative to controls, thus resulting in a substantial decrease in the formation of TCM cells
45 days post-infection [55]. Consequently, TGF-b signaling and miR200 repression in CD8+ T cells during viral infection
(at least for LCMV) seem to uncouple Zeb1 and Zeb2 expression in such a way as to control effector and memory states.
Although only limited data are available for myeloid cells, it is tempting to speculate that a similar feedback loop may
exist. For example, in monocytes, deletion of Zeb2 leads to increased expression of Zeb1 [7]. Moreover, with GMP
differentiation, monocytes and neutrophils display differential dependence on Zeb2 and expression of Zeb1. Like-
wise, in DCs, ZEB2 must be absent for normal cDC1 development to take place [7,14]. However, ZEB1 has been
reported to be required for normal cytokine production by cDC1s following CpG stimulation [19]. Moreover, a role for
TGF-b signaling and miR-200 family regulation remains be investigated in DCs, but as peripheral cDC1s are known to
express CD103 (an integrin regulated by TGF-b signaling), hypothetically, this regulatory network might exist.
Similarly, in the intestine, CD103+ cDC2 development is ZEB2-independent, unlike CD103 cDC2s. Furthermore,
because CD103+ cDC2s require TGF-b for their development [65], it is also tempting to speculate that a similar
regulatory network to that observed for T cells might be present in cDC2s.
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key elements of this regulatory network in T cells [55] (Box 3). Future studies should focus on
furthering our knowledge of such differential regulatory networks, and of how they might
modulate the functions of ZEB family members.
ZEB2 in Mature CD4+ T Cells
The generation of effector CD4+ T cells is crucial for host protection. Following activation with
antigen, naïve CD4+ T cells undergo proliferation and differentiation into different T helper subsets
depending on the context of infection or inﬂammation. Unlike CD8+ T cells, the signiﬁcance of
ZEB2 in mature CD4+ T cell populations remains to be studied in detail; however, regulation of
Zeb2 expression has been suggested to be important for the maintenance of T regulatory cells
(Tregs) [56] (Figure 4). In mice and humans, FOXP3, the Treg lineage-deﬁning TF, cooperates with
miRNAs to repress target genes, reinforcing a suppressor phenotype [56]. Speciﬁcally, in mice,
miR-155 with FOXP3 targets the effector-associated gene, Zeb2 [57]. ZEB2 may also contribute
to the generation of effector CD4+ T cells following infection, and Zeb2 expression has been
reported to be somewhat increased in murine CD4+T cells at day 7 of LCMV-Arm infection relative
to naïve cells (Figure 2). The signiﬁcance of these ﬁndings remains to be discerned, but a closer
examination of subset-speciﬁc transcriptional regulation following infection and inﬂammation
might uncover speciﬁc roles for ZEBs in CD4+ T cells (see Outstanding Questions).
ZEB2 in Innate Lymphocytes
NK cells, a predominant innate lymphocyte population, are an important defense against intra-
cellular pathogens and cancers. Similarly to T cells, NK cells can secrete proinﬂammatory
cytokines, IFN-g, and tumor necrosis factor (TNF)-a, and also possess cytolytic function. In
mammals, NK development takes place in the BM, and upon commitment to the cell lineage, NK
cells undergo a series of developmental steps towards terminal maturation, losing their ability to
proliferate while gaining effector function and unique trafﬁcking ability [58]. High expression of
Zeb2 in themost mature humanand mouse NK cell subsetshas been observed (Figure 2) [59], and
is remarkably similar to that described for effector CD8+ T cell terminal differentiation (Box 3).
In line with this, the highest numbers of Zeb2-deﬁcient NK cells have been described in the BM,
with lower numbers in the blood and peripheral tissues; these mice exhibit a complete lack of
mature CD27 NK cells in all organs analyzed [59] (Figure 4). Accordingly, overexpression of
Zeb2 has been reported to cause a reduction in BM NK cell numbers without altering spleen cell
counts. However, in this study a signiﬁcant increase in mature CD27NK cells was observed in
both BM and spleen relative to WT controls [59]. Careful examination of Zeb2 deﬁciency has
suggested that the absence of mature peripheral CD27 NK cells may be due to reduced
viability and impaired cell trafﬁcking [59]. ZEB2 has been directly or indirectly implicated in
modulating IL-15-mediated survival as well as proper egress of developing NK cells from the
BM; however, further in vivo analyses will be necessary to further understand these roles [59].
Of note, in a melanoma tumor model, mice harboring Zeb2-deﬁcient NK cells were reported to
be highly susceptible to B16 melanoma outgrowth, and displayed a substantially increased
number of lung and liver nodules compared with controls [59]. Functionally, Zeb2-deﬁcient NK
cells were able to migrate in response to chemokines, degranulate, and produce IFN-g;
however, KO mice harbored only 15% of normal WT NK numbers in the lungs. This
suggested that low NK numbers – and not altered functionality – might have been responsible
for the heightened susceptibility to melanoma [59].
Although warranting further investigation, such observations in NK cells parallel conclusions
drawn from studies of effector CD8+ T cell terminal differentiation that demonstrate a crucialTrends in Immunology, May 2019, Vol. 40, No. 5 443
Outstanding Questions
Why does ZEB2 deletion only have a
minor, but intrinsic, effect on cDC2s?
Are there undeﬁned subsets of cDC2s
with differential dependence on ZEB2?
Is there a critical threshold of ID2
expression in these? If ZEB2 must
be absent to generate cDC1s, at what
stage of development can we deﬁne
cDC1-committed progenitors?
What role does ZEB1 play in cDCs in
vivo?
Given the upregulation of ZEB1 in
ZEB2-deﬁcient monocytes, coupled
with expression of other neutrophil-
associated genes, what is the role of
ZEB1 in neutrophils?
Eosinophils express high levels of
Zeb2; is there any role for ZEBs in
eosinophil biology?
To date, most research on myeloid
cells has focused on cell develop-
ment/maintenance. What are the func-
tional consequences of ZEB1/2 loss in
myeloid cells?
Upon activation, naive B cells generate
a heterogeneous population of prog-
eny, including terminally differentiated
plasma cells, germinal center B cells,
and memory B cells; do ZEBs function
in regulating these distinct paths of
differentiation?
Because Zeb1 is more highly
expressed in CD4+ T cell populations
than Zeb2, what is the precise role (if
any) of ZEB1 and ZEB2 in regulating
the development and maintenance of
CD4+ T cells?
Given the considerable transcriptional
overlap between mature differentiated
CD4+ and CD8+ T cells following infec-requirement for ZEB2 as part of a transcriptional network that directs terminal maturation. Of
note, recent studies have ascribed features of adaptive immunity to NK cell responses – such
as an antigen-driven expansion followed by a contraction phase, and the establishment of a
long-lived and self-renewing population of NK memory cells [60]. Moreover, global proﬁling of
Ly49H+ NK cells over the course of mouse cytomegalovirus (MCMV) infection in mice has
identiﬁed a common epigenetic and transcriptional signature shared by memory NK cells and
memory CD8+ T cells [61]. Zeb2 was identiﬁed within this signature, suggesting that it may play
a role not only in the regulation of CD8+ T cell differentiation but, presumably, also in the
generation of NK cell memory [61].
With the description of innate lymphoid cell (ILC) families, it will also be important to consider
the role of the ZEBs in innate lymphocytes other than NK cells. Considerable similarities in
transcriptional regulation have already been noted between ILCs and T cells [62]. However,
although the expression of Zeb2 in murine ILCs is somewhat low, Zeb1 expression seems to
occur reciprocally to that of Zeb2; consistent with that described above for CD8+ T cell
populations (Figure 2). Furthermore, ZEB functions in the gd T cell (Tgd cell) lineage remain
to be examined. Thus, future studies deﬁning the precise function of ZEB proteins in the
differentiation and function of innate lymphocyte populations might allow a more thorough
understanding of immune defense, as well as of any putative common regulatory pathways that
may be shared between innate lymphocytes and T cells, and perhaps also B cells.
Concluding Remarks
In recent years our understanding of the roles of ZEB proteins has signiﬁcantly increased. In
addition to driving EMT, ZEBs are also expressed by many cells of the immune system where
they play crucial roles in regulating development, differentiation, maintenance, and other
functions. These ﬁndings have opened interesting avenues of research, raising many questions
regarding the varied functions of ZEB proteins across immune compartments (see Outstanding
Questions). It will be important to determine how our understanding of ZEBs from mouse
models translates to the human immune system. This is particularly relevant in the context of
Mowat–Wilson syndrome where patients harbor heterozygous expression of ZEB2. Thus, the
functional relevance of ZEB protein haploinsufﬁciencies in immune defense requires further
examination.
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